EP2982759B1 - Procédé de purification d'acide quinoléique - Google Patents
Procédé de purification d'acide quinoléique Download PDFInfo
- Publication number
- EP2982759B1 EP2982759B1 EP14778283.3A EP14778283A EP2982759B1 EP 2982759 B1 EP2982759 B1 EP 2982759B1 EP 14778283 A EP14778283 A EP 14778283A EP 2982759 B1 EP2982759 B1 EP 2982759B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- crystals
- acidic composition
- quinolinic acid
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- GJAWHXHKYYXBSV-UHFFFAOYSA-N quinolinic acid Chemical compound OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 title claims description 145
- 238000000034 method Methods 0.000 title claims description 59
- 239000013078 crystal Substances 0.000 claims description 152
- 239000000203 mixture Substances 0.000 claims description 89
- 239000000243 solution Substances 0.000 claims description 85
- 230000002378 acidificating effect Effects 0.000 claims description 83
- 238000000855 fermentation Methods 0.000 claims description 81
- 230000004151 fermentation Effects 0.000 claims description 81
- 239000002253 acid Substances 0.000 claims description 36
- 238000007670 refining Methods 0.000 claims description 35
- 239000003637 basic solution Substances 0.000 claims description 33
- 230000000813 microbial effect Effects 0.000 claims description 28
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 24
- 238000004140 cleaning Methods 0.000 claims description 24
- 239000012535 impurity Substances 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 18
- 239000010413 mother solution Substances 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 11
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 6
- 229910017604 nitric acid Inorganic materials 0.000 claims description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000011148 porous material Substances 0.000 description 13
- 238000001914 filtration Methods 0.000 description 12
- 239000012528 membrane Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 9
- 229910021641 deionized water Inorganic materials 0.000 description 9
- 239000002198 insoluble material Substances 0.000 description 9
- 244000005700 microbiome Species 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000001953 recrystallisation Methods 0.000 description 8
- 230000003134 recirculating effect Effects 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- -1 CO3 2- Chemical class 0.000 description 5
- 239000003929 acidic solution Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000011007 phosphoric acid Nutrition 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 238000010306 acid treatment Methods 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 150000001879 copper Chemical class 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- HPYNZHMRTTWQTB-UHFFFAOYSA-N 2,3-dimethylpyridine Chemical compound CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 229910003944 H3 PO4 Inorganic materials 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000520272 Pantoea Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- AOYKZPYPQXTVPL-UHFFFAOYSA-N azanium quinoline-2-carboxylate Chemical compound [NH4+].[O-]C(=O)c1ccc2ccccc2n1 AOYKZPYPQXTVPL-UHFFFAOYSA-N 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- IEXLHMWSNGVXFY-UHFFFAOYSA-L magnesium;quinoline-2-carboxylate Chemical compound [Mg+2].C1=CC=CC2=NC(C(=O)[O-])=CC=C21.C1=CC=CC2=NC(C(=O)[O-])=CC=C21 IEXLHMWSNGVXFY-UHFFFAOYSA-L 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- PLTCLMZAIZEHGD-UHFFFAOYSA-M sodium;quinoline-2-carboxylate Chemical compound [Na+].C1=CC=CC2=NC(C(=O)[O-])=CC=C21 PLTCLMZAIZEHGD-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/803—Processes of preparation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
Definitions
- the present invention relates to a method of refining quinolinic acid.
- Quinolinic acid is a compound that is widely used as an intermediate for medicines, dyes, agricultural pesticides, and the like.
- quinolinic acid is chemically prepared from a starting material such as quinoline, 2,3-dimethylpyridine, or 8-hydroxyquinoline obtained in petrochemical processes.
- a chemical synthesis method of quinolinic acid includes obtaining a copper salt of quinolinic acid from a sulfate such as copper sulfate; and removing copper ions from the copper salt in a form of copper oxide precipitate.
- the additional process of removing copper from copper salt of quinolinic acid may lead to generation of a large amount of byproducts and a low yield.
- the synthesis method may also result in a large amount of impurities, and thus, it may also be difficult to obtain quinolinic acid with a high yield with the synthesis method, even by recirculating a mother solution resulting from separation of crystals of quinolinic acid.
- quinolinic acid In recent times, there has been research into methods of producing quinolinic acid through a fermentation process. Producing quinolinic acid through a fermentation process is simple and results in a small amount of byproducts. However, a fermentation solution resulting from the fermentation process may include, in general, a low concentration of quinolinic acid, which is present as a combination with a salt.
- the present invention provides a novel, economical method of purifying quinolinic acid from a fermentation solution.
- a method of refining quinolinic acid including: preparing a fermentation solution including at least one of quinolinic acid and a salt thereof; removing microbial cells from the fermentation solution; preparing an acidic composition including the at least one of quinolinic acid and a salt thereof at a saturation concentration or more by adding an acid to the fermentation solution from which the microbial cells were removed; and recovering crystals of the at least one of quinolinic acid and a salt thereof from the acidic composition wherein the acidic composition has a pH of 1.0 to 2.5, and wherein the acid comprises at least one selected from sulfuric acid, hydrochloric acid, nitric acid, bromic acid (HBr), phosphoric acid (H3 PO4), perchloric acid (HC104), and a mixture thereof.
- quinolinic acid may be refined through a relatively simple process via adding an acid to a fermentation solution including quinolinic acid.
- High-purity quinolinic acid may be obtained with a high yield by recirculating a mother solution resulting from crystal separation following acid treatment.
- a method of refining quinolinic acid includes: preparing a fermentation solution including at least one of quinolinic acid and a salt thereof; removing microbial cells from the fermentation solution; preparing an acidic composition including the at least one of quinolinic acid and a salt thereof at a saturation concentration or more by adding an acid to the fermentation solution from which the microbial cells were removed; and recovering a crystal of the at least one of quinolinic acid and a salt thereof from the acidic composition wherein the acidic composition has a pH of 1.0 to 2.5, and wherein the acid comprises at least one selected from sulfuric acid, hydrochloric acid, nitric acid, bromic acid (HBr), phosphoric acid (H3PO4), perchloric acid (HC104), and a mixture thereof.
- high-purity quinolinic acid may be obtained with a high yield through simple processes by adding an acid to the fermentation solution including a salt of quinolinic acid to form a crystal of quinolinic acid and then recovering the crystal of quinolinic acid. Since the acidic composition includes at least one of quinolinic acid and a salt thereof at a saturation concentration or more, at least part of the at least one of quinolinic acid and a salt thereof may be precipitated as crystals.
- the fermentation solution used in the refining method may be a fermentation solution cultured with a modified microorganism able to produce quinolinic acid.
- Types of microorganisms available to prepare the fermentation solution are not specifically limited, and may include any microorganism able to produce quinolinic acid available in the art.
- the microorganism available in the refining method may be a microorganism belonging to the genus Escherichia, Enterobacter, Erwinia, Klebsiella, Pantoea, Serratia, Corynebacterium, and the like.
- the fermentation solution may further include, in addition to quinolinic acid: an organic acid, such as lactic acid, succinic acid, formic acid, or acetic acid; cations such as Na + , Mg 2+ , NH 4 + , and K + ; anions such as CO 3 2- , PO 4- , and SO 4 2- ; amino acids such as valine, arginine, and methionine; an non-consumable carbon source, an microorganism available for fermentation having the ability to produce quinolinic acid, and the like.
- an organic acid such as lactic acid, succinic acid, formic acid, or acetic acid
- cations such as Na + , Mg 2+ , NH 4 + , and K +
- anions such as CO 3 2- , PO 4- , and SO 4 2-
- amino acids such as valine, arginine, and methionine
- an non-consumable carbon source an microorganism available for fermentation having the ability to produce quinolinic acid,
- the acidic composition in the refining method has a pH from 1.0 to 2.5.
- the fermentation solution before the adding of an acid may have a pH of about 4 to about 9.
- the quinolinic acid may bind to cations such as Na + , Mg 2+ , NH 4 + , K + , and the like contained in a culture medium and consequentially be present as a salt thereof such as sodium quinolinate, magnesium quinolinate, ammonium quinolinate, or potassium, having a comparative high solubility of about 100g/L or higher in water.
- precipitated crystals of quinolinic acid may be mixed with crystals of quinolinate.
- the acidic composition having a pH of 1.0 to 2.5 may be prepared by adding an acid to the fermentation solution.
- the acidic composition in the preparing of the acidic composition, may have a temperature of 60°C or less, and in some embodiments, 50°C or less, and in some other embodiments, 40°C or less, and in some other embodiments, 0°C to 40°C.
- the acid added to the culture medium include at least one selected from sulfuric acid, hydrochloric acid, nitric acid, bromic acid (HBr), phosphoric acid (H 3 PO 4 ), perchloric acid (HClO 4 ), and a mixture thereof.
- the concentration of the added acid is also not specifically limited.
- the refining method may include removing microbial cells from the fermentation solution before the preparing of the acidic composition.
- the removing of microbial cells may be performed, but not limited to, using a centrifuge, a filter press, a diatomaceous earth filter, a rotary vacuum filter, or a membrane separator, or by adding a coagulating agent, a floating agent, or the like. Any method available in the art to separate microbial cells may be used.
- the fermentation solution conventionally may have a pH of about 4 to about 9.
- the pH of the fermentation solution may be reduced by adding an acid to agglomerate microbial cells to be effectively removed.
- the pH of the fermentation solution at which the microbial cells may agglomerate to be effectively removed may be in a range of from about 3 to about 7, and in some embodiments, about 3.5 to about 6.0.
- the pH of the fermentation solution is not limited thereto, and may be in a range in which agglomeration of microbial cells occurs by addition of an acid.
- the acid added to the fermentation solution may be sulfuric acid, hydrochloric acid, nitric acid, or a mixture thereof, but is not limited thereto. Any acid available in the art to adjust the pH of the fermentation solution may be used.
- the microbial cells that are removed from the fermentation solution may be dried for use as animal feed or fertilizer.
- the refining method may further include, before the preparing of the acidic composition, removing impurities from the fermentation solution.
- the purity of quinolinic acid may be improved by the removal of impurities.
- the removing of impurities from the fermentation solution may include adding a filtering agent to the fermentation solution to remove impurities and/or insoluble materials.
- the filtering agent may be, for example, activated carbon, diamaceous earth, bentonate, acidic terra alba, talc, or the like, but is not limited thereto. Any filtering agent available in the art may be used.
- the filtering agent to which impurities and insoluble materials are adsorbed may be removed from the fermentation solution by using a filter.
- the impurities may include a metal ion.
- the insoluble materials may include, for example, microbial cells.
- the refining method may further include, before the preparing of the acidic composition, concentrating the fermentation solution.
- the yield of crystals of quinolinic acid may be increased by the further concentrating of the fermentation solution.
- the concentrating of the fermentation solution may include removing water to increase the concentration of quinolinic acid in the fermentation solution, and consequently increase the amount of precipitated crystals of quinolinic acid in a subsequent step.
- the refining method may further include, after the preparing of the acidic composition, concentrating the acidic composition.
- the concentrating of the acidic solution may include removing water used as a solvent to increase the concentration of quinolinic acid in the acidic composition, and consequentially increase the amount of precipitated crystals of quinolinic acid.
- the crystals resulting from the concentrating of the acidic composition are concentrated crystals of quinolinic acid.
- a recovery rate of quinolinic acid crystals may be improved by the removal of the solvent in the concentrating of the acidic composition.
- a concentration of quinolinic acid concentrated in the concentrating step may be from about 50 g/L to about 400 g/L, and in some embodiments, about 80 g/L to about 300 g/L.
- the concentrating of the acidic solution may be performed using, but not limited to, a condenser selected from the group consisting of a centrifugal concentrator, an evaporative condenser, a convection circulation concentrator, a low-temperature vacuum evaporator, a rotary evaporator, a reduced pressure evaporator, a thin-film evaporator, and a plate evaporator. Any concentrator available in the art may be used.
- the concentrating of the acidic solution may be performed using a low-temperature vacuum evaporator.
- a pressure of the low-temperature vacuum evaporator may be in a range of about 10 mmHg to about 760 mmHg, and in some embodiments, about 70 mmHg to about 200 mmHg.
- a temperature of the low-temperature vacuum evaporator may be in a range of about 10°C to about 100°C and in some embodiments, about 40°C to about 100°C.
- the refining method may further include, after the preparing of the acidic composition, cooling the acidic composition.
- the yield of quinolinic acid crystals may be increased by the further cooling of the acidic composition.
- the further cooling of the acidic composition may reduce the solubility of quinolinic acid, and consequentially increase the amount of precipitated crystals of quinolinic acid.
- the crystals resulting from the cooling are cooled crystals of qninolinic acid.
- the cooling of the acidic composition may be performed by natural cooling or controlled cooling.
- the controlled cooling may be performed at a cooling rate of about 0.01 °C/min to about 5°C/min.
- the lower the cooling temperature the higher the yield of crystals may become, but the lower the purity of precipitated crystals may become. Accordingly, the cooling temperature may be appropriately controlled in consideration of the yield and purity of precipitated crystals.
- the cooling temperature may be in a range of about 0°C to about 40°C and in some embodiments, about 2°C to about 30 °C.
- the refining method may further include, after the preparing of the acidic composition, adding a quinolinic acid crystal seed to the acidic composition. Precipitation of quinolinic acid crystals may be accelerated by the addition of the quinolinic acid crystal seed.
- the adding of the quinolinic acid crystal seed may stimulate generation and growth of quinolinic acid crystals, and thus increase the size and purity of recovered crystals of quinolinic acid.
- the refining method may further include, after the recovering of the crystals, recrystallizing the recovered crystals.
- the purity of recovered crystals may be further improved by the recrystallization of the recovered crystals.
- the recovering of the crystals may include separating the crystals from the acidic composition.
- the separating of the crystals from the acidic composition is separating precipitated crystals from the acidic composition.
- the separating of precipitated crystals may be performed using any common separation method available in the art, not limited to a specific method.
- the separating of precipitated crystals may be performed using a filtration device, such as a filter.
- the separated crystals may be readily used in the recrystalling process without additional treatment.
- the recovering of the crystals may further include cleaning and drying the separated crystals.
- the cleaning of the separated crystals may be performed using water or a cleaning solution such as an aqueous quinolinic acid solution. Impurities adhered to the crystals of quinolinic acid may be removed by the cleaning of the separated crystals.
- the amount of the cleaning solution used in the cleaning of the crystals may be about 100% or less of a total weight of the separated crystals.
- the amount of the cleaning solution used in the cleaning of the crystals may be about 50% or less, and in some embodiments, about 20% or less, and in some other embodiments, about 10% or less, based on the total weight of the separated crystals.
- the drying of the separated crystals may be performed using, but not limited to, common atmospheric or reduced-pressure drying. Any drying method available in the art may be used.
- all or some of a mother solution, obtained from the recovering of crystals can be recirculated into the fermentation solution.
- the mother solution resulting from the separating of precipitated crystals in the recovering of the crystals is an acidic solution containing an acid.
- the acid in the mother solution may be reused by the recirculating of the mother solution. Accordingly, the yield of crystals of quinolinic acid may be improved through the recirculating step.
- the yield of crystals of quinolinic acid obtained by the refining method may be about 50% or greater.
- the yield of crystals of quinolinic acid obtained by the refining method may be about 60% or greater, and in some embodiments, about 70% or greater, and in some other embodiments, about 80% or greater, and in still other embodiments, about 90% or greater, and in yet other embodiments, about 95% or greater, and in still yet other embodiments, about 99% or greater.
- a method of refining quinolinic acid will be described with reference to FIG. 2 .
- the resulting fermentation solution may be concentrated.
- An acid may be added to the concentrated fermentation solution to obtain an acidic composition, followed by crystallizing quinolinic acid.
- After filtering precipitated crystals of quinolinic acid, cleaning and drying may be performed to yield crystals of quinolinic acid.
- a mother solution resulting from the separating of crystals of quinolinic acid may undergo an additional treatment, and then be added back to the fermentation solution from which microbial cells were removed.
- the refining method may further include, after the recovering of the crystals, recrystallizing the recovered crystals.
- the yield of the recovered crystals may be further improved by the recrystallization.
- the recrystallizing of the recovered crystals may include: dissolving the recovered crystals in a basic solution; preparing an acidic composition including at least one of quinolinic acid and a salt thereof at a saturation concentration by adding an acid to the basic solution; and recovering crystals of the at least one of quinolinic acid and a salt thereof from the acidic composition.
- the recovered crystals may be fully dissolved in the basic solution.
- Quinolinic acid may be completely dissolved in the form of ions in the basic solution.
- the basic solution may include at least one selected from the group consisting of calcium hydroxide, magnesium hydroxide, calcium carbonate, ammonium hydroxide, sodium hydroxide, barium hydroxide, magnesium carbonate, and a mixture thereof, but is not limited thereto. Any base available in the art may be used.
- a concentration of the basic solution is not specifically limited provided that it is within a range of fully dissolving about 30 g/L to about 400 g/L of quinolinic acid and maintaining a pH of the basic solution at about 3.5 to about 8.0.
- the basic solution may include a base in an amount that is equivalent to about 0.1 to about 5 times of moles of quinolinic acid.
- the temperature of the basic solution may be increased to improve the solubility of the recovered crystals.
- the temperature of the basic solution may be less than about 100°C, and in some embodiments, about 80°C or less, and in some other embodiments, about 60°C or less.
- the preparing of the acidic composition including at least one of quinolinic acid and a salt thereof at a saturation concentration by adding an acid to the basic solution is the same as the preparing of an acidic composition by adding an acid to the fermentation solution, except that an acid is added to the basic solution, instead of the fermentation solution.
- the purity of the crystals may be improved by the recrystallization using the basic solution including the recovered crystals, instead of the fermentation solution.
- an acidic composition having a pH of about 3.5 or less, for example, about 1.5 to about 2.5, at which the solubility of quinolinic acid is rapidly reduced may be prepared by adding an acid to the basic solution.
- the acid may be sulfuric acid, hydrochloric acid, nitric acid, or a mixture thereof, but is not limited thereto. Any acid available in the art may be used.
- a temperature of the basic solution is not specifically limited, and may be in a range of about 0°C to about 60°C to improve the yield of the recrystallized crystals.
- the temperature of the basic solution may be in a range of about 0°C to about 40°C.
- the acidic composition having a pH of about 3.5 or less may be further concentrated, or the temperature of the acidic composition may be further reduced, thus to increase the amount of the crystals.
- the refining method may further include removing impurities from the basic solution before the preparing of the acidic composition.
- the purity of refined quinolinic acid may be further improved by the removal of impurities.
- Impurities and/or insoluble materials may be removed by adding a filtering agent to the basic solution.
- the filtering agent may be, for example, activated carbon, diamaceous earth, bentonate, acidic terra alba, talc, or the like, but is not limited thereto. Any filtering agent available in the art may be used.
- the filtering agent to which impurities or insoluble materials are adsorbed may be removed from the basic solution by using a filter.
- the impurities may include a metal ion.
- the insoluble material may include, for example, microbial cells.
- the recovering of the crystals of the at least one of quinolinic acid and a salt thereof may include separating the crystals from the acidic composition.
- the method of refining quinolinic acid may be terminated by the separating of the crystals without additional treatment.
- the recovering of the crystals may further include cleaning and drying the separated crystals.
- the separating of the crystals from the acidic composition and the cleaning and drying of the separated crystals may be the same as the above described steps of separating, cleaning and drying in the recovering of the crystals of at least one of quinolinic acid and a salt thereof, except that the recrystallized crystals, instead of the primary crystals, are separated, cleaned, and dried.
- the recovering of the recrystallized crystals, not the primary crystals, may improve the purity of the crystals.
- all or some of a mother solution obtained from the recovering of the crystals can be recirculated into the fermentation solution.
- the mother solution resulting from the separating of precipitated crystals in the recovering of the recrystallized crystals is an acidic solution containing an acid.
- the acid in the mother solution may be reused by the recirculating of the mother solution. Accordingly, the yield of crystals of quinolinic acid may be improved through the recirculating step.
- the resulting crystals of quinolinic acid may have a purity of about 90% or greater, and in some embodiments, about 95% or greater, and in some other embodiments, about 98% or greater, and in still other embodiments, about 99% or greater, and in yet other embodiments, about 99.2% or greater.
- a method of refining quinolinic acid, according to another exemplary embodiment, will be described with reference to FIG. 3 .
- the resulting fermentation solution may be concentrated.
- An acid may be added to the concentrated fermentation solution to obtain an acidic composition, followed by crystallizing quinolinic acid. After filtering precipitated crystals of quinolinic acid, cleaning and drying may be performed to yield crystals of quinolinic acid. After completely dissolving the crystals of quinolinic acid in a basic solution, an acid may be added to the basic solution to obtain an acid composition and recrystallize quinolinic acid. The recrystallized quinolinic acid may separated by filtering, followed by cleaning and drying to yield crystals of quinolinic acid. A mother solution resulting from the separating of crystals of quinolinic acid may undergo an additional treatment, and then be added back to the fermentation solution from which microbial cells were removed.
- a first fermentation solution was prepared by the CJ CheilJedang Bioscience R&D center.
- the prepared first fermentation solution included about 3.75wt% of quinolinic acid, about 0.52wt% of organic acids (lactic acid, succinic acid, formic acid, acetic acid, etc.), about 1.25wt% of ions (cations such as Na + , Mg 2+ , NH 4+ , and K + , and anions such as CO 3 2- , PO 4- , and SO 4 2- ), about 0.04wt% of amino acids (valine , arginine, methionine, etc.), about 0.66wt% of other components (microorganisms, Fe 2+ , Cu 2+ , carbohydrate, etc.), and about 93.78 wt% of water.
- Microbial cells were removed from the first fermentation solution (concentration of quinolinic acid: 39 g/L, pH 5.6) by using a membrane filter (cartridge type, Pellicon 2, available from Millipore).
- the membrane filter had a pore size of about 0.1 ⁇ m and a membrane area of about 0.5 m 2 .
- Water was removed from 915 mL of the first fermentation solution from which impurities were removed, by using a rotary evaporator at about 50°C for about 3 hours to concentrate a concentration of quinolinic acid to about 120 g/L.
- Precipitated crystals of quinolinic acid in the acidic composition were separated using a vacuum filter (filter pore size: 8 ⁇ m), followed by cleaning the crystals with 80g of deionized water, and drying in a 60 ⁇ -oven for about 3 hours.
- Quinolinic acid was refined in the same manner as in Example 1, except that the pH of the acidic composition was changed to 2.0, and the concentrated concentration of quinolinic acid in the concentration step was about 120 g/L.
- Quinolinic acid was refined in the same manner as in Example 1, except that the pH of the acidic composition was changed to 2.5, and the concentrated concentration of quinolinic acid in the concentration step was about 120 g/L.
- Quinolinic acid was refined in the same manner as in Example 1, except that the pH of the acidic composition was changed to 3.0, and the concentrated concentration of quinolinic acid in the concentration step was about 150g/L.
- Example 5 Refining method including recrystallization step
- a second fermentation solution (available from the CJ CheilJedang Bioscience R&D center) was prepared.
- the prepared second fermentation solution included about 4.00wt% of quinolinic acid, about 0.43wt% of organic acids (lactic acid, succinic acid, formic acid, acetic acid, etc.), about 1.38wt% of ions (cations such as Na + , Mg 2+ , NH 4+ , and K + , and anions such as CO 3 2- , PO 4- , and SO 4 2- ), about 0.05wt% of amino acids (valine, arginine, methionine, etc.), about 1.42wt% of other components (microorganisms, Fe 2+ , Cu 2+ , carbohydrate, etc.), and about 92.72 wt% of water.
- Microbial cells were removed from the second fermentation solution (concentration of quinolinic acid: 42 g/L, pH 5.6) by using a membrane filter (cartridge type, Pellicon 2, available from Millipore).
- the membrane filter had a pore size of about 0.1 ⁇ m and a membrane area of about 0.5 m 2 .
- Precipitated crystals of quinolinic acid in the acidic composition were separated using a vacuum filter (filter pore size: 8 ⁇ m), followed by cleaning the crystals with 80g of deionized water and drying in a 60°C -oven for about 3 hours to obtain 40.26 g of crystals of quinolinic acid.
- the recovered crystals were dissolved in deionized water and analyzed by high-performance liquid chromatography (HPLC). As a result, the purity of the crystals of quinolinic acid was about 95.3%.
- Precipitated crystals of quinolinic acid in the acidic composition were separated using a vacuum filter (filter pore size: 8 ⁇ m), followed by cleaning the crystals with 30 g of deionized water, and drying in a 60°C -oven for about 3 hours to obtain 26.5 g of crystals of quinolinic acid (Crystal recovery step).
- Example 6 Refining method including recrystallization step
- a second fermentation solution (available from the CJ CheilJedang Bioscience R&D center) as used in Example 5 was prepared.
- Microbial cells were removed from the second fermentation solution (concentration of quinolinic acid: 42 g/L, pH 5.6) by using a membrane filter (cartridge type, Pellicon 2, available from Millipore).
- the membrane filter had a pore size of about 0.1 ⁇ m and a membrane area of about 0.5 m 2 .
- Precipitated crystals of quinolinic acid in the acidic composition were separated using a vacuum filter (filter pore size: 8 ⁇ m), followed by cleaning the crystals with 80 g of deionized water and drying in a 60°C -oven for about 3 hours to obtain 57.6 g of crystals of quinolinic acid.
- the recovered crystals were dissolved in deionized water and analyzed by HPLC. As a result, the purity of the crystals of quinolinic acid was about 93.9%.
- Precipitated crystals of quinolinic acid in the concentrated acidic composition were separated using a vacuum filter (filter pore size: 8 ⁇ m), followed by cleaning the crystals with 12 g of deionized water and drying in a 60°C -oven for about 3 hours to obtain 48.5 g of crystals of quinolinic acid (Crystal recovery step).
- Quinolinic acid was refined in the same manner as in Example 1, except that the pH of the acidic composition was changed to 4.0, and the concentrated concentration of quinolinic acid in the concentration step was about 400 g/L.
- Evaluation Example 2 Evaluation of yield and purity of crystals with respect to pH of acidic composition
- quinolinic acid may be refined through a comparatively simple process via adding an acid to a fermentation solution including quinolinic acid.
- High-purity quinolinic acid may be obtained with a high yield by recirculating a mother solution resulting from acid treatment and crystal separation acid treatment.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Claims (12)
- Procédé de purification d'acide quinoléique, le procédé comprenant :la préparation d'une solution de fermentation incluant au moins l'un parmi l'acide quinoléique et un sel de celui-ci ;le retrait de cellules microbiennes à partir de la solution de fermentation ;la préparation d'une composition acide incluant au moins l'un parmi l'acide quinoléique et un de ses sels à une concentration de saturation ou supérieure en ajoutant un acide à la solution de fermentation de laquelle les cellules microbiennes ont été retirées ; etla récupération de cristaux d'au moins un parmi l'acide quinoléique et un sel de celui-ci à partir de la composition acide, où la composition acide a un pH de 1,0 à 2,5, etoù l'acide comprend au moins un acide choisi parmi l'acide sulfurique, l'acide chlorhydrique, l'acide nitrique, l'acide bromhydrique (HBr), l'acide phosphorique (H3PO4), l'acide perchlorique (HClO4), et un mélange de ceux-ci.
- Procédé selon la revendication 1, dans lequel, dans la préparation de la composition acide, la composition acide a une température de 40 °C ou moins.
- Procédé selon la revendication 1, comprenant en outre, avant la préparation de la composition acide, le retrait d'impuretés de la solution de fermentation.
- Procédé selon la revendication 1, comprenant en outre, avant la préparation de la composition acide, la concentration de la solution de fermentation.
- Procédé selon la revendication 1, comprenant en outre, après la préparation de la composition acide, la concentration de la composition acide.
- Procédé selon la revendication 1, comprenant en outre, après la préparation de la composition acide, le refroidissement de la composition acide.
- Procédé selon la revendication 1, comprenant en outre, après la préparation de la composition acide, l'addition d'un germe cristallin d'acide quinoléique à la composition acide.
- Procédé selon la revendication 1, comprenant en outre, après la récupération des cristaux, la recristallisation des cristaux récupérés.
- Procédé selon la revendication 8, dans lequel la récupération des cristaux comprend la séparation des cristaux de la composition acide.
- Procédé selon la revendication 8, dans lequel la récupération des cristaux comprend en outre le nettoyage et le séchage des cristaux séparés.
- Procédé selon la revendication 1, dans lequel une solution mère, obtenue à partir de la récupération des cristaux, est remise en circulation dans la solution de fermentation.
- Procédé selon la revendication 8, dans lequel la recristallisation des cristaux récupérés comprend : la dissolution des cristaux récupérés dans une solution basique ;
la préparation d'une composition acide incluant au moins l'un parmi l'acide quinoléique et un sel de celui-ci à une concentration de saturation ou plus par l'addition d'un acide à la solution basique ; et
la récupération de cristaux d'au moins un parmi l'acide quinoléique et un sel de celui-ci à partir de la composition acide.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130035462A KR101395558B1 (ko) | 2013-04-01 | 2013-04-01 | 퀴놀린산의 정제방법 |
PCT/KR2014/001833 WO2014163301A1 (fr) | 2013-04-01 | 2014-03-06 | Procédé de purification d'acide quinoléique |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2982759A1 EP2982759A1 (fr) | 2016-02-10 |
EP2982759A4 EP2982759A4 (fr) | 2016-08-24 |
EP2982759B1 true EP2982759B1 (fr) | 2018-07-18 |
Family
ID=50894235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14778283.3A Active EP2982759B1 (fr) | 2013-04-01 | 2014-03-06 | Procédé de purification d'acide quinoléique |
Country Status (6)
Country | Link |
---|---|
US (1) | US9452983B2 (fr) |
EP (1) | EP2982759B1 (fr) |
KR (1) | KR101395558B1 (fr) |
CN (1) | CN105074000B (fr) |
BR (1) | BR112015024985B1 (fr) |
WO (1) | WO2014163301A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115032285B (zh) * | 2021-03-08 | 2024-01-02 | 远大生命科学(武汉)有限公司 | 一种吲哚喹啉酸有关物质的rt-hplc检测方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4537971A (en) | 1981-05-06 | 1985-08-27 | The Hilton-Davis Chemical Co. | Process for preparing quinolinic acid |
JPS5886090A (ja) * | 1981-11-17 | 1983-05-23 | Mitsui Petrochem Ind Ltd | ジカルボン酸の分離方法 |
DE3826041A1 (de) * | 1988-07-30 | 1990-02-08 | Ruetgerswerke Ag | Verfahren zur herstellung von chinolinsaeure |
CN102399182A (zh) * | 2010-09-08 | 2012-04-04 | 鞍钢股份有限公司 | 喹啉酸的生产方法 |
KR101223904B1 (ko) | 2011-01-14 | 2013-01-21 | 씨제이제일제당 (주) | 니코틴산의 제조 방법 |
-
2013
- 2013-04-01 KR KR1020130035462A patent/KR101395558B1/ko active IP Right Grant
-
2014
- 2014-03-06 BR BR112015024985-0A patent/BR112015024985B1/pt active IP Right Grant
- 2014-03-06 EP EP14778283.3A patent/EP2982759B1/fr active Active
- 2014-03-06 US US14/779,886 patent/US9452983B2/en active Active
- 2014-03-06 WO PCT/KR2014/001833 patent/WO2014163301A1/fr active Application Filing
- 2014-03-06 CN CN201480018771.1A patent/CN105074000B/zh active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
EP2982759A1 (fr) | 2016-02-10 |
KR101395558B1 (ko) | 2014-05-16 |
BR112015024985A2 (pt) | 2017-07-18 |
US9452983B2 (en) | 2016-09-27 |
CN105074000B (zh) | 2018-12-21 |
WO2014163301A1 (fr) | 2014-10-09 |
EP2982759A4 (fr) | 2016-08-24 |
BR112015024985B1 (pt) | 2021-11-16 |
CN105074000A (zh) | 2015-11-18 |
US20160052885A1 (en) | 2016-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5814946B2 (ja) | コハク酸を製造する方法 | |
CN109134287B (zh) | 一种甜菜碱或甜菜碱盐酸盐生产中副产氯化钠的提纯方法 | |
CN101914098B (zh) | 美罗培南三水合物结晶的制备方法 | |
JP2016101170A (ja) | 発酵液から1,4−ジアミノブタンを分離及び精製する方法 | |
EP2982759B1 (fr) | Procédé de purification d'acide quinoléique | |
CN108558908B (zh) | 一种头孢他啶母液的除盐方法及头孢他啶的制备方法 | |
JP2008043327A (ja) | コハク酸の製造方法 | |
CN110330441B (zh) | 一种d-亮氨酸的提纯方法 | |
US4667054A (en) | Process for producing optically active valine | |
EP4215539A1 (fr) | Procédé de purification d'ester de sucralose-6-éthyle | |
KR20170036231A (ko) | 도데칸디오익산 정제 방법 | |
JPH0115496B2 (fr) | ||
CN110655535A (zh) | 一种替诺福韦的纯化方法 | |
CN105949127B (zh) | 一种咪唑苯脲的提纯方法 | |
CN112142740A (zh) | 亚胺培南的制备方法 | |
EP1727784B1 (fr) | Procede ameliore pour la preparation de gabapentine | |
CN110436488A (zh) | 一种制备高纯单水氢氧化锂专用混合剂 | |
TW202403050A (zh) | 用於自醱酵液或醱酵廢液回收及再循環磷酸的方法 | |
US20070060560A1 (en) | Process for producing the dihydrochloride of amino acids | |
WO2014097221A1 (fr) | Procédé pour la purification de biapenem | |
CN111777636A (zh) | 一种用于心肌保护的药物的制备方法 | |
US2845433A (en) | Extraction of 4-amino-3-isoxazolidone | |
CN116143650A (zh) | 一种盐酸四环素的结晶方法 | |
JP2010006752A (ja) | 4−アミノシクロヘキサン−1−カルボン酸のシス/トランス異性体混合物の分離方法 | |
JP2012096996A (ja) | ビタミンd誘導体の結晶化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20151026 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20160722 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12P 17/12 20060101AFI20160715BHEP Ipc: C07D 215/22 20060101ALI20160715BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20180212 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: ISLER AND PEDRAZZINI AG, CH Ref country code: AT Ref legal event code: REF Ref document number: 1019400 Country of ref document: AT Kind code of ref document: T Effective date: 20180815 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014028777 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1019400 Country of ref document: AT Kind code of ref document: T Effective date: 20180718 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181018 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181018 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181019 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181118 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014028777 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 |
|
26N | No opposition filed |
Effective date: 20190423 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190306 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190306 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190306 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20140306 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180718 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230606 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20231121 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20231121 Year of fee payment: 11 Ref country code: FR Payment date: 20231121 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20231121 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20231120 Year of fee payment: 11 Ref country code: GB Payment date: 20240105 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20231121 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240401 Year of fee payment: 11 |